[Clinically significant interaction between the new diuretic--tienienilic acid and the antithrombotic drugs, derivatives of coumarin].
D000368:Aged; D004347:Drug Interactions; D004487:Edema / Q000188:drug therapy; D005017:Ethyl Biscoumacetate / Q000009:adverse effects*; D005260:Female; D006016:Glycolates / Q000009:adverse effects*; D006801:Humans; D008297:Male; D013927:Thrombosis / Q000188:drug therapy; D013989:Ticrynafen / Q000009:adverse effects*
D006016:Glycolates; D005017:Ethyl Biscoumacetate; D013989:Ticrynafen
Klinicznie znamienna interakcja nowego leku moczopednego, kwasu tienylowego z lekami przeciwzakrzepowymi pochodynmi kumaryny.